Saroja Pharma Industries India Limited — Resignation

Saroja Pharma Industries India Limited has informed stock exchanges that its statutory auditors, M/s Pravin Chandak & Associates, have resigned from their position effective October 26, 2026. This change in the company's audit team is a routine administrative update that does not indicate any financial irregularities or audit failures.

For investors, this news is generally neutral and not a cause for immediate concern. Statutory auditors are required to sign off on the company's financial statements, and their resignation is usually a standard part of the audit cycle. The company will now need to appoint new auditors to ensure the audit process continues without interruption.

Investors should monitor the company's future announcements to see when a new auditor is appointed. This ensures that the company's financial reporting remains transparent and compliant with all regulatory requirements.